Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 01, 2026
TickeronGET DAILY SIGNALS
Vanguard Small-Cap ETF (VB): Diversified Exposure to U.S. Small Caps in a High-Rate Setting

Vanguard Small-Cap ETF (VB): Diversified Exposure to U.S. Small Caps in a High-Rate Setting

Key Takeaways

  • VB tracks the CRSP US Small Cap Index, a broad benchmark spanning U.S. companies in the lower band of the investable market-capitalization spectrum.
  • The fund holds roughly 1,300 stocks, with industrials (about 20%) and technology (about 18%) as its largest sector weights, followed by financial services and healthcare.
  • VB is passively managed with a 0.03% expense ratio and more than $170 billion in assets under management (AUM), making it one of the largest U.S. small-cap ETFs.
  • Over the trailing 30 days, VB has edged roughly 2% higher, while remaining near flat over the trailing quarter as elevated interest rates kept small-cap momentum in check.
  • Because no single position exceeds about 0.7% of assets, returns are driven by broad sector and macroeconomic forces rather than any individual stock.
  • For additional context on this ETF's outlook, review the latest Price Targets and Forecast pages.
  • Investors can also explore Trending AI Robots to see how AI-driven strategies are approaching the current market environment.

Overview of Vanguard Small-Cap ETF (VB)

Vanguard Small-Cap ETF (VB) is a passively managed exchange-traded fund that seeks to track the CRSP US Small Cap Index before fees and expenses. The index represents U.S. companies falling roughly between the bottom 2% and 15% of the investable equity market by capitalization, creating a small-cap blend that spans both growth and value profiles. VB uses a full-replication approach, holding stocks in approximately the same proportions as the index.

The portfolio contains more than 1,300 holdings, which limits single-stock risk. Top positions include Credo Technology Group (CRDO), Jabil (JBL), Astera Labs (ALAB), Natera (NTRA), Revolution Medicines (RVMD), and EMCOR Group (EME), each representing well under 1% of assets. Sector exposure is led by industrials (about 20%) and technology (about 18%), with financial services and healthcare each near 12%–13%, followed by consumer cyclical and real estate. The fund carries a net expense ratio of 0.03%. I also checked the latest holdings breakdown using Tickeron’s AI tools to confirm the sector allocations.

The Industry and Thematic Landscape

Small-cap equities entered a more challenging phase during the latter part of 2026 after outperforming large caps through the first half of the year. The primary headwind has been interest rates: the 10-year U.S. Treasury yield moved above 5%, raising financing costs for smaller companies that rely more heavily on floating-rate debt and external capital. This asymmetry has disproportionately pressured longer-duration and less-profitable small caps even as large-cap leaders remained resilient.

At the same time, the domestic economy has stayed relatively firm. The S&P Global Manufacturing Purchasing Managers' Index reached its strongest reading in more than four years, and labor-market conditions remained broadly stable. Inflation, however, has lingered above target, with the Consumer Price Index (CPI) and core inflation measures keeping policymakers cautious. This combination of resilient activity and sticky inflation has supported cyclical industrial and financial names while restraining rate-sensitive growth segments, shaping a market environment that favors diversified, multi-sector exposure over concentrated bets.

Performance and Positioning Snapshot

VB has been essentially range-bound in recent weeks. Over the trailing 30 days, the fund advanced roughly 2%, while over the trailing quarter it was slightly lower, reflecting the flat performance of the small-cap complex as a whole. This is consistent with broader small-cap benchmarks, which gave back first-half leadership gains as longer-dated yields climbed.

The fund's sector mix helps explain this behavior. Its substantial industrials and technology exposure ties it to domestic manufacturing and the artificial-intelligence build-out, areas where many smaller suppliers of specialized equipment and components have continued to grow. Meanwhile, its healthcare weight includes biotechnology names that are more sensitive to financing conditions, and its financial services exposure remains linked to the path of interest rates. With earnings revisions mixed across the small-cap universe, VB's broad diversification has muted single-stock volatility, leaving macro factors such as Treasury yields and inflation expectations as the dominant drivers of recent performance.

2026 Outlook and Key Factors to Monitor

Several structural factors are likely to shape VB's trajectory over the remainder of 2026 and beyond. Interest-rate policy remains central: additional Federal Reserve tightening would raise financing costs for smaller, more leveraged companies, while a pause or shift toward easing could relieve a key constraint on small-cap valuations. Inflation trends, particularly in energy and services, will influence that path.

Domestic economic growth is another important variable. Because small-cap revenue is heavily concentrated in the United States, VB is closely tied to manufacturing activity, consumer spending, and credit conditions. The artificial-intelligence build-out may continue to benefit specialized industrial and technology suppliers within the fund, though any slowdown in that capital-expenditure cycle would ripple across holdings. Healthcare innovation and biotechnology financing conditions, along with merger and acquisition activity, also represent potential catalysts. Investors should monitor sector rotation, earnings revisions among small-cap constituents, and capital flows into small-cap ETFs as signals of whether the current consolidation gives way to renewed leadership or further range-bound trading. One thing that stands out is how these macro variables could shift the relative performance of small caps versus large caps going forward.

Using Tickeron’s AI Screener for Research

Tickeron’s AI Screener is an AI-powered stock and ETF discovery platform designed to help investors scan thousands of securities using technical indicators, fundamentals, volatility measures, AI-generated signals, market trends, price patterns, and customizable filters. The tool enables users to surface trending securities, breakout candidates, and new trading opportunities more efficiently than manual screening. For those researching diversified small-cap strategies or identifying momentum and value setups across sectors, the screener provides a structured way to narrow the universe. I find it useful when comparing VB to similar funds in the space.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: VB

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


VB sees MACD Histogram crosses below signal line

VB saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 53 instances where the indicator turned negative. In 46 of the 53 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VB as a result. In 75 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

VB moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VB crossed bearishly below the 50-day moving average on November 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

The Aroon Indicator for VB entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for VB's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +3.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where VB advanced for three days, in 273 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

VB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Notable companies

The most notable companies in this group are Moderna (NASDAQ:MRNA), Centene Corp (NYSE:CNC), Illumina (NASDAQ:ILMN), Twilio (NYSE:TWLO), EQT Corp (NYSE:EQT), Okta (NASDAQ:OKTA), Incyte Corp (NASDAQ:INCY), Roku (NASDAQ:ROKU), Dow (NYSE:DOW), Southwest Airlines Co (NYSE:LUV).

Industry description

The investment seeks to track the performance of the CRSP U.S. Small Cap Index that measures the investment return of small-capitalization stocks. The fund advisor employs an indexing investment approach designed to track the performance of the CRSP U.S. Small Cap Index, a broadly diversified index of stocks of small U.S. companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Market Cap

The average market capitalization across the Vanguard Morningstar Small-Cap ETF (VB) ETF is 6.65B. The market cap for tickers in the group ranges from 203.84M to 101.48B. MRNA holds the highest valuation in this group at 101.48B. The lowest valued company is CCOI at 203.84M.

High and low price notable news

The average weekly price growth across all stocks in the Vanguard Morningstar Small-Cap ETF (VB) ETF was -7%. For the same ETF, the average monthly price growth was -6%, and the average quarterly price growth was -6%. BRBR experienced the highest price growth at 38%, while YSS experienced the biggest fall at -37%.

Volume

The average weekly volume growth across all stocks in the Vanguard Morningstar Small-Cap ETF (VB) ETF was 45%. For the same stocks of the ETF, the average monthly volume growth was 38% and the average quarterly volume growth was 4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 53
Price Growth Rating: 53
SMR Rating: 64
Profit Risk Rating: 76
Seasonality Score: 13 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.